Functional Contrast-Enhanced CT for Evaluation of Acute Ischemic Stroke Does Not Increase the Risk of Contrast-Induced Nephropathy

References

1. 1.↵
   1. Smith WS,
   2. Roberts HC,
   3. Chuang NA,
   4. et al

   . Safety and feasibility of a CT protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients. AJNR Am J Neuroradiol 2003;24:688–90

   Abstract/FREE Full Text
2. 2.↵
   1. Lev MH,
   2. Farkas J,
   3. Rodriguez VR,
   4. et al

   . CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr 2001;25:520–28

   CrossRefPubMed
3. 3.↵
   1. Wintermark M,
   2. Reichhart M,
   3. Thiran JP,
   4. et al

   . Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002;51:417–32

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Nash K,
   2. Hafeez A,
   3. Hou S

   . Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930–36

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Gruberg L,
   2. Mintz GS,
   3. Mehran R,
   4. et al

   . The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542–48

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Morcos SK,
   2. Thomsen HS,
   3. Webb JA

   . Contrast-media-induced nephrotoxicity: a consensus report—Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 1999;9:1602–13

   CrossRefPubMedWeb of Science
7. 7.↵
   1. McCullough PA,
   2. Adam A,
   3. Becker CR,
   4. et al

   . Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006;98:5K–13K

   PubMedWeb of Science
8. 8.↵
   1. Mehran R,
   2. Nikolsky E

   . Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 2006:S11–15
9. 9.↵
   1. Rao QA,
   2. Newhouse JH

   . Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 2006;239:392–97

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Wyman RM,
    2. Safian RD,
    3. Portway V,
    4. et al

    . Current complications of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol 1988;12:1400–06

    PubMedWeb of Science
11. 11.↵
    1. Langner S,
    2. Stumpe S,
    3. Kirsch M,
    4. et al

    . No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium. AJNR Am J Neuroradiol 2008;29:1525–29

    Abstract/FREE Full Text
12. 12.↵
    1. Cramer BC,
    2. Parfrey PS,
    3. Hutchinson TA,
    4. et al

    . Renal function following infusion of radiologic contrast material: a prospective controlled study. Arch Intern Med 1985;145:87–89

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Heller CA,
    2. Knapp J,
    3. Halliday J,
    4. et al

    . Failure to demonstrate contrast nephrotoxicity. Med J Aust 1991;155:329–32

    PubMed
14. 14.↵
    1. Newhouse JH,
    2. Kho D,
    3. Rao QA,
    4. et al

    . Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 2008;191:376–82

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Levey AS,
    2. Bosch JP,
    3. Lewis JB,
    4. et al

    . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation—Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461–70

    CrossRefPubMedWeb of Science
16. 16.↵
    National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (2 suppl 1): S1– 266

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Krol AL,
    2. Dzialowski I,
    3. Roy J,
    4. et al

    . Incidence of radiocontrast nephropathy in patients undergoing acute stroke computed tomography angiography. Stroke 2007;38:2364–66

    Abstract/FREE Full Text
18. 18.↵
    1. Hopyan JJ,
    2. Gladstone DJ,
    3. Mallia G,
    4. et al

    . Renal safety of CT angiography and perfusion imaging in the emergency evaluation of acute stroke. AJNR Am J Neuroradiol 2008;29:1826–30.Epub 2008 Aug 21

    Abstract/FREE Full Text
19. 19.↵
    1. McCullough PA,
    2. Wolyn R,
    3. Rocher LL,
    4. et al

    . Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368–75

    CrossRefPubMedWeb of Science
20. 20.↵
    1. McCullough PA,
    2. Sandberg KR

    . Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 2003;4(suppl 5):S3–9
21. 21.↵
    1. Persson PB,
    2. Hansell P,
    3. Liss P

    . Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68:14–22

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Josephson SA,
    2. Dillon WP,
    3. Smith WS

    . Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging. Neurology 2005;64:1805–06

    Abstract/FREE Full Text
23. 23.↵
    1. Solomon R,
    2. Deray G

    . How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. Kidney Int Suppl 2006:S51–53